IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers
NCT04584515
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
IMP4297 40 mg
DRUG:
IMP4297 100 mg
Sponsor
Impact Therapeutics, Inc.